The following strategies are priority areas:

• Targeting adenoviruses to tumors
• Oncolytic adenoviruses and other oncolytic viruses
• Imaging of gene therapy agents and tumor models
• Gene therapy in combination with other therapeutics
• Enhancing systemic delivery of gene therapy agents
• Arming oncolytic viruses for improved efficacy
• Stem cells and cancer stem cells
• Immunology of gene therapy
• Immunotherapy of cancer
• Translating preclinical results into clinical trials

In particular, the following diseases are of interest:

• Ovarian cancer
• Hormone refractory prostate cancer
• Metastatic breast cancer
• Lung cancer
• Metastatic colorectal cancer
• Pancreatic cancer
• Gastric cancer
• Kidney cancer
• Head and neck cancer